Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 948-951, 2004; 10.1373/clinchem.2003.030932
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubel, C. A.
Right arrow Articles by Roberts, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubel, C. A.
Right arrow Articles by Roberts, J. M.
Related Collections
Right arrow Nutrition
Right arrow Proteomics and Protein Markers
Right arrow Hematology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:948-951.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Nonglycosylated Ferritin Predominates in the Circulation of Women with Preeclampsia but Not Intrauterine Growth Restriction

Carl A. Hubel1,a, Lisa M. Bodnar1, Ariel Many3, Gail Harger2, Roberta B. Ness1,2 and James M. Roberts1,2

1 Magee-Womens Research Institute and Department of Obstetrics and Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA2 Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA3 Lis Maternity Hospital, Sourasky Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

aaddress correspondence to this author at: Magee-Womens Research Institute, 204 Craft Ave., Pittsburgh, PA 15213; fax 412-641-1-503, e-mail rsicah@mwri.magee.edu)

The first 300 words of the full text of this article appear below.

Three to five percent of pregnancies are complicated by preeclampsia, a multisystemic disorder characterized by hypertension and proteinuria that occurs after 20 weeks of gestation. Although widespread inflammation and endothelial dysfunction appear to be central maternal abnormalities in preeclampsia, the pathogenesis of the syndrome remains poorly understood (1).

The intracellular iron storage protein ferritin can hold up to 4000 iron atoms. Low concentrations of ferritin are found in normal serum because of active secretion from reticuloendothelial or parencymal cells (2)(3). During normal pregnancy, serum ferritin concentrations decrease with advancing gestation to reach a nadir at the third trimester (4). The metabolism of the serum iron and iron-binding proteins, ferritin and transferrin, is abnormal in women with preeclampsia (5)(6)(7)(8). Median serum ferritin concentrations are approximately fivefold higher during preeclampsia than in normal pregnancy (6)(8)(9). The lowest quartile of ferritin concentrations at 28–30 weeks of gestation is associated with decreased risk of preeclampsia, premature rupture of membranes, and infant admission to the neonatal unit (4). The reasons for the increased serum ferritin with preeclampsia remain unclear. Serum ferritin is a reliable indicator of total body iron status in nondiseased individuals, with low concentrations diagnostic of iron deficiency. However, a high ferritin does not always signify iron excess.

Unlike intracellular ferritin, which is nonglycosylated and high in iron, normal serum ferritin is 60–80% glycosylated and very low in iron, suggesting active secretion rather than nonspecific leakage from cells (2)(10). Blood concentrations of ferritin increase with inflammation or infection as a result of augmented intracellular synthesis (2)(11). In such cases, the proportion of glycosylated serum ferritin is basically unchanged, and the serum . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
J. Lipid Res.Home page
K. R. Atkinson, M. Blumenstein, M. A. Black, S. H. Wu, N. Kasabov, R. S. Taylor, G. J. S. Cooper, R. A. North, and on behalf of the SCOPE Consortium
An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia
J. Lipid Res., January 1, 2009; 50(1): 71 - 80.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.